Jump to content

Serotonin: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Line 35: Line 35:
== Function ==
== Function ==


In the [[central nervous system]], serotonin plays an important role as a [[neurotransmitter]] in the modulation of [[anger]], [[aggression]], [[Thermoregulation|body temperature]], [[Mood (psychology)|mood]], [[sleep]], [[Human sexuality]], [[appetite]], and [[metabolism]], as well as stimulating [[vomiting]].<ref>http://drugs.emedtv.com/dolasetron/dolasetron.html</ref>
In the [[central nervous system]], serotonin plays an important role as a [[neurotransmitter]] in the modulation of [[anger]], [[aggression]], [[Thermoregulation|body temperature]], [[Mood (psychology)|mood]], [[sleep]], [[human sexuality]], [[appetite]], and [[metabolism]], as well as stimulating [[vomiting]].<ref>http://drugs.emedtv.com/dolasetron/dolasetron.html</ref>


Serotonin has broad activities in the brain, and genetic variation in serotonin receptors and the [[serotonin transporter]], which facilitates reuptake of serotonin into presynapses, have been implicated in neurological diseases. Drugs targeting serotonin-induced pathways are being used in the treatment of many psychiatric disorders, and one focus of clinical research is the influence of genetics on serotonin action and metabolism in psychiatric settings. Such studies have revealed that the variation in the promoter region of the serotonin transporter protein accounts for nearly 10% of total variance in anxiety-related personality,<ref> {{Cite journal | author = Lesch, K.; Bengel, D.; Heils, A.; Sabol, S. Z.; Greenberg, B. D.; Petri, S.; Clemens, R.; Müller, J. B.; Hamer, D. H.; Murphy, D. L. | title = Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region | journal = [[Science]] | year = 1996 | volume = 274 | pages = 1527–31 | doi = 10.1126/science.274.5292.1527 | pmid = 8929413}}</ref> and the effect of this gene on [[Major depressive disorder|depression]] was found to interact with the environment.<ref>{{Cite journal | author = Caspi, A.; Sugden, K.; Moffitt, T. E.; Taylor, A.; Craig, I. W.; Harrington, W.; McClay, J.; Mill, J.; Martin, J.; Braithwaite, A.; Poulton, R. | title = Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene | journal = [[Science]] | year = 2003 | volume = 301 | pages = 386–89 | doi = 10.1126/science.1083968 | pmid = 12869766}}</ref>
Serotonin has broad activities in the brain, and genetic variation in serotonin receptors and the [[serotonin transporter]], which facilitates reuptake of serotonin into presynapses, have been implicated in neurological diseases. Drugs targeting serotonin-induced pathways are being used in the treatment of many psychiatric disorders, and one focus of clinical research is the influence of genetics on serotonin action and metabolism in psychiatric settings. Such studies have revealed that the variation in the promoter region of the serotonin transporter protein accounts for nearly 10% of total variance in anxiety-related personality,<ref> {{Cite journal | author = Lesch, K.; Bengel, D.; Heils, A.; Sabol, S. Z.; Greenberg, B. D.; Petri, S.; Clemens, R.; Müller, J. B.; Hamer, D. H.; Murphy, D. L. | title = Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region | journal = [[Science]] | year = 1996 | volume = 274 | pages = 1527–31 | doi = 10.1126/science.274.5292.1527 | pmid = 8929413}}</ref> and the effect of this gene on [[Major depressive disorder|depression]] was found to interact with the environment.<ref>{{Cite journal | author = Caspi, A.; Sugden, K.; Moffitt, T. E.; Taylor, A.; Craig, I. W.; Harrington, W.; McClay, J.; Mill, J.; Martin, J.; Braithwaite, A.; Poulton, R. | title = Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene | journal = [[Science]] | year = 2003 | volume = 301 | pages = 386–89 | doi = 10.1126/science.1083968 | pmid = 12869766}}</ref>

Revision as of 23:36, 4 December 2008

For the professional wrestling stable, see Raven's Nest § Serotonin.
Serotonin
Names
IUPAC names
5-Hydroxytryptamine or
3-(2-aminoethyl)-1H-indol-5-ol
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.000.054 Edit this at Wikidata
MeSH Serotonin
  • InChI=1/C10H12N2O/c11-4-3-7-6-12-10-2-1- 8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2
  • NCCc1c[nH]c2ccc(O)cc12
Properties
C10H12N2O
Molar mass 176.215
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Serotonin (Template:PronEng) (5-hydroxytryptamine, or 5-HT) is a monoamine neurotransmitter synthesized in serotonergic neurons in the central nervous system (CNS) and enterochromaffin cells in the gastrointestinal tract of animals including humans. Serotonin is also found in many mushrooms and plants, including fruits and vegetables.

Function

In the central nervous system, serotonin plays an important role as a neurotransmitter in the modulation of anger, aggression, body temperature, mood, sleep, human sexuality, appetite, and metabolism, as well as stimulating vomiting.[1]

Serotonin has broad activities in the brain, and genetic variation in serotonin receptors and the serotonin transporter, which facilitates reuptake of serotonin into presynapses, have been implicated in neurological diseases. Drugs targeting serotonin-induced pathways are being used in the treatment of many psychiatric disorders, and one focus of clinical research is the influence of genetics on serotonin action and metabolism in psychiatric settings. Such studies have revealed that the variation in the promoter region of the serotonin transporter protein accounts for nearly 10% of total variance in anxiety-related personality,[2] and the effect of this gene on depression was found to interact with the environment.[3]

Levels of serotonin in the brain show association with aggression (Caspi et al. 2002), and a mutation in the gene which codes for the 5-HT2A receptor may double the risk of suicide for those with that genotype.[4]

Using the ultimatum game as model, it was shown that people whose serotonin levels have been artificially lowered will reject unfair offers more often than players with normal serotonin levels.[5]

In addition, serotonin is also a peripheral signal mediator. It is found extensively in the human gastrointestinal tract as about 80-90% of the body's total serotonin is found in the enterochromaffin cells in the gut.[6][7] In the blood, the major storage site is platelets, which collect serotonin for use in mediating post-injury vasoconstriction.[8]

Recent research suggests that serotonin plays an important role in liver regeneration and acts as a mitogen (induces cell division) throughout the body. Recent research also suggests that intestinal serotonin may inhibit bone formation. [2] [9]

Serotonin and SIDS

Defective signalling of serotonin in the brain may be the root cause of sudden infant death syndrome (SIDS), Italian researchers have found. Scientists from the European Molecular Biology Laboratory in Monterotondo, Italy,[10] genetically modified lab mice to produce low levels of the brain signaling protein serotonin. The results showed the mice suffered drops in heart rate and other symptoms of SIDS, and many of the animals died at an early age.

Researchers now believe that low levels of serotonin in the animals' brainstems, which control heartbeat and breathing, may have caused sudden death, researchers said in the July 4, 2008 issue of Science.[11]

Anatomy

Gross anatomy

The neurons of the raphe nuclei are the principal source of 5-HT release in the brain.[12] The raphe nuclei are neurons grouped into about nine pairs and distributed along the entire length of the brainstem, centered around the reticular formation.[13]

Axons from the neurons of the raphe nuclei form a neurotransmitter system, reaching large areas of the brain. Axons of neurons in the caudal dorsal raphe nucleus terminate in the following locations:

On the other hand, axons of neurons in the rostral dorsal raphe nucleus terminate in e.g.:

Thus, activation of this serotonin system has effects on large areas of the brain.

Microanatomy

Serotonin is released from serotonergic varicosities (swellings) into the extra neuronal space, but not from synaptic terminal boutons as other neurotransmitters. [citation needed] Serotonin diffuses over a relatively wide gap (>20µm) to activate 5-HT receptors located on the dendrites, cell bodies and presynaptic terminals of adjacent neurons.

Receptors

Main article: 5-HT receptor

5-HT receptors are the receptors for serotonin. They are located on the cell membrane of nerve cells and other cell types in animals and mediate the effects of serotonin as the endogenous ligand and of a broad range of pharmaceutical and hallucinogenic drugs. With the exception of the 5-HT3 receptor, a ligand gated ion channel, all other 5-HT receptors are G protein coupled seven transmembrane (or heptahelical) receptors that activate an intracellular second messenger cascade. [citation needed]

Termination

Serotonergic action is terminated primarily via uptake of 5-HT from the synapse. This is through the specific monoamine transporter for 5-HT, 5-HT reuptake transporter, on the presynaptic neuron. Various agents can inhibit 5-HT reuptake including MDMA (ecstasy), amphetamine, cocaine, dextromethorphan (an antitussive), tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs).

Endothelial cell function and Serotonin

5-hydroxytryptamine evokes endothelial nitric oxide synthase activation and stimulates phosphorylation of p44/p42 mitogen-activated protein kinase activation in bovine aortic endothelial cell cultures.[14]

Synthesis

The pathway for the synthesis of serotonin from tryptophan

In the body, serotonin is synthesized from the amino acid tryptophan by a short metabolic pathway consisting of two enzymes: tryptophan hydroxylase (TPH) and amino acid decarboxylase (DDC). The TPH-mediated reaction is the rate-limiting step in the pathway. TPH has been shown to exist in two forms: TPH1, found in several tissues, and TPH2, which is a brain-specific isoform. There is evidence that genetic polymorphisms in both these subtypes influence susceptibility to anxiety and depression. There is also evidence that ovarian hormones can affect the expression of TPH in various species, suggesting a possible mechanism for postpartum depression and premenstrual stress syndrome.

Serotonin taken orally does not pass into the serotonergic pathways of the central nervous system because it does not cross the blood-brain barrier. However, tryptophan and its metabolite 5-hydroxytryptophan (5-HTP), from which serotonin is synthesized, can and do cross the blood-brain barrier. These agents are available as dietary supplements and may be effective serotonergic agents.

One product of serotonin breakdown is 5-Hydroxyindoleacetic acid (5 HIAA), which is excreted in the urine. Serotonin and 5 HIAA are sometimes produced in excess amounts by certain tumors or cancers, and levels of these substances may be measured in the urine to test for these tumors.

Drugs targeting the 5-HT system

Several classes of drugs target the 5-HT system including some antidepressants, antipsychotics, anxiolytics, antiemetics, and antimigraine drugs as well as the psychedelic drugs and empathogens.

Psychedelic drugs

The psychedelic drugs psilocin/psilocybin, DMT, mescaline, and LSD mimic the action of serotonin primarily at 5-HT2A receptor. The empathogen MDMA (ecstasy) releases serotonin from synaptic vesicles of neurons.

Antidepressants

The MAOIs prevent the breakdown of monoamine neurotransmitters (including serotonin), and therefore increase concentrations of the neurotransmitter in the brain. MAOI therapy is associated with many adverse drug reactions, and patients are at risk of hypertensive emergency triggered by foods with high tyramine content and certain drugs.

Some drugs inhibit the re-uptake of serotonin, making it stay in the synapse longer. The tricyclic antidepressants (TCAs) inhibit the re-uptake of both serotonin and norepinephrine. The newer selective serotonin re-uptake inhibitors (SSRIs) have fewer side-effects and fewer interactions with other drugs.

SSRI medications have been shown to lower serotonin levels below initial level over time, despite initial increases in serotonin. [15] This decrease in level did not rectify after the medicine was discontinued. However, the novel antidepressant Tianeptine, selective serotonin reuptake enhancer, has mood elevating effects. This has given evidence to the theory that serotonin is most likely used to regulate the extent or intensity of moods, and that low levels are what's associated with SSRI sexual dysfunction and/or "mood blunting" experienced by people on these medications.

Antiemetics

5-HT3 antagonists such as ondansetron, granisetron, and tropisetron are important antiemetic agents. They are particularly important in treating the nausea and vomiting that occur during anticancer chemotherapy using cytotoxic drugs. Another application is in treatment of post-operative nausea and vomiting. Applications to the treatment of depression and other mental and psychological conditions have also been investigated with some positive results.

Pathology

If neurons that make serotonin — serotonergic neurons — are abnormal in infants, there is a risk of sudden infant death syndrome (SIDS).[16][17] Low levels of serotonin may also be associated with intense spiritual experiences.[18]

Recent research conducted at Rockefeller University shows that both in patients who suffer from depression and in mice that model the disorder, levels of the p11 protein are decreased. This protein is related to serotonin transmission within the brain.[19]

Obsessive-compulsive disorder (OCD) can be a debilitating disorder with the following two anxiety-related essential features: obsessions (undesirable, recurrent, disturbing thoughts) and compulsions (repetitive or ritualized behaviors). SSRIs, and other medicines which alter serotonin levels, have been approved to be used to treat symptoms of OCD.

Serotonin syndrome

Main article: serotonin syndrome

Extremely high levels of serotonin can have toxic and potentially fatal effects, causing a condition known as serotonin syndrome. In practice, such toxic levels are essentially impossible to reach through an overdose of a single anti-depressant drug, but require a combination of serotonergic agents, such as an SSRI with an MAOI.[20] The intensity of the symptoms of serotonin syndrome vary over a wide spectrum, and the milder forms are seen even at non-toxic levels.[21] For example, recreational doses of MDMA (ecstasy) will generally cause such symptoms but only rarely lead to true toxicity.[citation needed]

Chronic diseases resulting from serotonin 5-HT2B overstimulation

Main article: Cardiac fibrosis

In blood, serotonin stored in platelets is active wherever platelets bind, as a vasoconstrictor to stop bleeding, and also as a fibrocyte mitotic, to aid healing. Because of these effects, overdoses of serotonin, or serotonin agonist drugs, may cause acute or chronic pulmonary hypertension from pulmonary vasoconstriction, or else syndromes of retroperitoneal fibrosis or cardiac valve fibrosis (endocardial fibrosis) from overstimulation of serotonic growth receptors on fibrocytes.[citation needed]

Serotonin itself may cause a syndrome of cardiac fibrosis when it is eaten in large quantities in the diet (the Matoki banana of East Africa) or when it is over-secreted by certain mid-gut carcinoid tumors.[citation needed] The valvular fibrosis in such cases is typically on the right side of the heart, since excess serotonin in the serum outside platelets is metabolized in the lungs, and does not reach the left circulation.[citation needed]

Serotonergic agonist drugs in overdose in experimental animals not only cause acute (and sometimes fatal) pulmonary hypertension, but there is epidemiologic evidence that chronic use of certain of these drugs produce a chronic pulmonary hypertensive syndrome in humans.[citation needed] Some serotonergic agonist drugs also cause fibrosis anywhere in the body, particularly the syndrome of retroperitoneal fibrosis, as well as cardiac valve fibrosis.[22]

In the past, three groups of serotonergic drugs have been epidemiolgically linked with these syndromes. They are the serotonergic vasoconstrictive anti-migraine drugs (ergotamine and methysergide),[22] the serotonergic appetite suppressant drugs (fenfluramine, chlorphentermine, and aminorex), and certain anti-parkinsonian dopaminergic agonists, which also stimulate serotonergic 5-HT2B receptors. These include pergolide and cabergoline, but not the more dopamine-specific lisuride.[23] As with fenfluramine, some of these drugs have been withdrawn from the market after groups taking them showed a statistical increase of one or more of the side effects described. An example is pergolide. The drug was in decreasing use since reported in 2003 to be associated with cardiac fibrosis.[24] Two independent studies published in the New England Journal of Medicine in January 2007, implicated pergolide along with cabergoline in causing valvular heart disease.[25][26] As a result of this, the FDA removed pergolide from the U.S. market in March, 2007.[27] (Since cabergoline is not approved in the U.S. for Parkinson's Disease, but for hyperprolactinemia, the drug remains on the market. Treatment for hyperprolactinemia requires lower doses than that for Parkinson's Disease, diminishing the risk of valvular heart disease).[28]

Because neither the amino acid L-tryptophan nor the SSRI-class antidepressants raise blood serotonin levels [citation needed], they are not under suspicion to cause the syndromes described. However, since 5-hydroxytryptophan (5-HTP) does raise blood serotonin levels, it is under some of the same scrutiny as actively serotonergic drugs.[citation needed]

In unicellular organisms

Serotonin is used by a variety of single-cell organisms for various purposes. Selective serotonin re-uptake inhibitors (SSRIs) have been found to be toxic to algae.[29] The gastrointestinal parasite Entamoeba histolytica secretes serotonin, causing a sustained secretory diarrhea in some patients.[30][31] Patients infected with Entamoeba histolytica have been found to have highly elevated serum serotonin levels which returned to normal following resolution of the infection.[32] Entamoeba histolytica also responds to the presence of serotonin by becoming more virulent.[33]

In plants

Serotonin is found in mushrooms and plants, including fruits and vegetables. The highest values of 25–400 mg/kg have been found in nuts of the walnut (Juglans) and hickory (Carya) genuses. Serotonin concentrations of 3–30 mg/kg have been found in plantain, pineapple, banana, kiwifruit, plums, and tomatoes. Moderate levels from 0.1–3 mg/kg have been found in a wide range of tested vegetables.[34] Serotonin is one compound of the poison contained in the stinging hairs of the stinging nettle (Urtica dioica). It should be noted that serotonin, unlike its precursors 5-HTP and tryptophan, does not cross the blood–brain barrier, which means that ingesting serotonin in the diet has no effect on brain serotonin levels. Several plants contain serotonin together with a family of related tryptamines that are methylated at the amino (NH2) and hydroxy (OH) groups, are N-oxides, or miss the OH group. Examples are plants from the Anadenanthera genus that are used in the hallucinogenic yopo snuff.

In animals

Serotonin as a neurotransmitter is found in all animals, including insects. Several toad venoms, as well as that of the Brazilian wandering spider and stingray, contain serotonin and related tryptamines.

History

Isolated and named in 1948 by Maurice M. Rapport, Arda Green, and Irvine Page of the Cleveland Clinic,[35] the name serotonin is something of a misnomer and reflects the circumstances of the compound's discovery. It was initially identified as a vasoconstrictor substance in blood serum – hence serotonin, a serum agent affecting vascular tone. This agent was later chemically identified as 5-hydroxytryptamine (5-HT) by Rapport, and, as the broad range of physiological roles were elucidated, 5-HT became the preferred name in the pharmacological field.

Increasing serotonin levels

Serotonin levels may be increased by supplement of tryptophan. However, increasing foods rich in tryptophan (eg, meats, proteins) do not increase serotonin levels, due to competition with other amino acids.[36] What is required to increase serotonin production is an increase in the ratio of tryptophan to phenylalanine and leucine. Fruits with a good ratio include dates, papaya and banana. Foods with a lower ratio inhibit the production of seratonin. These include whole wheat and rye bread[37] Much research has indicated that vigorous aerobic exercise improves mood, believed to be facilitated by an increase in serotonin levels.[38] Research also suggests that eating a diet rich in whole grain carbohydrates and low in protein will increase serotonin by secreting insulin, which helps in amino acid competition.[36] However, increasing insulin for a long period of time can sometimes onset insulin resistance, which is related to obesity, type 2 diabetes, and lower serotonin levels. It is also believed that muscles use many of the amino acids except tryptophan, allowing men to have more serotonin than women.[39] Bright light therapy is another popular method which prevents the conversion of serotonin to melatonin.[40] A similar effect is obtained by spending more time in natural sunlight.

References

  1. ^ http://drugs.emedtv.com/dolasetron/dolasetron.html
  2. ^ Lesch, K.; Bengel, D.; Heils, A.; Sabol, S. Z.; Greenberg, B. D.; Petri, S.; Clemens, R.; Müller, J. B.; Hamer, D. H.; Murphy, D. L. (1996). "Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region". Science. 274: 1527–31. doi:10.1126/science.274.5292.1527. PMID 8929413.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Caspi, A.; Sugden, K.; Moffitt, T. E.; Taylor, A.; Craig, I. W.; Harrington, W.; McClay, J.; Mill, J.; Martin, J.; Braithwaite, A.; Poulton, R. (2003). "Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene". Science. 301: 386–89. doi:10.1126/science.1083968. PMID 12869766.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ Basky, Greg (2000). "Suicide linked to serotonin gene". CMAJ. 162 (9). {{cite journal}}: Unknown parameter |month= ignored (help)
  5. ^ Crockett, M. J.; Clark, L.; Tabibnia, G.; Lieberman, M. D.; Robbins, T. W. (2008). "Serotonin modulates behavioral reactions to unfairness". Science (journal). 320 (5884): 1739. doi:10.1126/science.1155577. PMC 2504725. PMID 18535210. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  6. ^ Indiana State University
  7. ^ [1] Serotonin tests info, Accessed May 6, 2008
  8. ^ Essentials of Human Anatomy & Physiology, Eighth Edition, p. 336
  9. ^ Cell 135, 825–837, November 28, 2008
  10. ^ Audero, Enrica; Coppi, Elisabetta; Mlinar, Boris; Rossetti, Tiziana; Caprioli, Antonio; Al Banchaabouchi, Mumna; Corradetti, Renato; Gross, Cornelius (2008). "Sporadic Autonomic Dysregulation and Death Associated with Excessive Serotonin Autoinhibition". Science. 321: 130–133. doi:10.1126/science.1157871. PMID 18599790.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  11. ^ Lesurtel, M.; et al. (2006). "Platelet-derived serotonin mediates liver regeneration". Science. 312 (5770): 104–7. doi:10.1126/science.1123842. PMID 16601191. {{cite journal}}: Explicit use of et al. in: |author= (help)
  12. ^ Frazer, A.; and Hensler, J. G. (1999). "Understanding the neuroanatomical organization of serotonergic cells in the brain provides insight into the functions of this neurotransmitter". In Siegel, G. J. (ed.). Basic Neurochemistry. Agranoff, Bernard W.; Fisher, Stephen K.; Albers, R. Wayne; Uhler, Michael D. (Sixth ed.). Lippincott Williams and Wilkins. ISBN 0-397-51820-X. In 1964, Dahlstrom and Fuxe (discussed in [2]), using the Falck-Hillarp technique of histofluorescence, observed that the majority of serotonergic soma are found in cell body groups, which previously had been designated as the raphe nuclei. {{cite book}}: External link in |chapterurl= (help); Unknown parameter |chapterurl= ignored (|chapter-url= suggested) (help)CS1 maint: multiple names: authors list (link)
  13. ^ |The Raphe nuclei group of neurons are located along the brain stem from the labels 'Mid Brain' to 'Oblongata', centered on the pons. (See relevant image.)
  14. ^ McDuffie, J. E. (2000). "-hydroxytryptamine stimulates phosphorylation of p44/p42 mitogen-activated protein kinase activation in bovine aortic endothelial cell cultures". J. Cardiovasc. Pharmacol. 35 (3). {{cite journal}}: Unknown parameter |month= ignored (help)
  15. ^ Benmansour, Saloua et al., Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level. Journal of Neuroscience, 1999, 19(23):10494-10501.
  16. ^ Paterson, D. S.; Trachtenberg, F. L.; Thompson, E.G.; et al. (2006). "Multiple serotonergic brainstem abnormalities in sudden infant death syndrome". JAMA. 296 (17): 2124–32. doi:10.1001/jama.296.17.2124. PMID 17077377. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  17. ^ Sciencedaily Report Anger and Aggression in Women: Blame It On Genetics
  18. ^ Farde, Lars; and Borg, Jacqueline; Section of psychiatry at Karolinska Institutet in Stockholm, Sweden 2003, the study and a vulgarized article
  19. ^ Svenningsson, P.; et al. (2006). "Alterations in 5-HT1B receptor function by p11 in depression-like states". Science. 311 (5757): 77–80. doi:10.1126/science.1117571. PMID 16400147. {{cite journal}}: Explicit use of et al. in: |author= (help)
  20. ^ Isbister, G. K.; Bowe, S. J.; Dawson, A.; Whyte, I. M. (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". J. Toxicol. Clin. Toxicol. 42 (3): 277–85. PMID 15362595.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  21. ^ Dunkley, E. J.; Isbister, G. K.; Sibbritt, D.; Dawson, A. H.; Whyte, I. M. (2003). "The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity". QJM. 96 (9): 635–42. PMID 12925718. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  22. ^ a b Baskin, Steven I. (1991). Principles of Cardiac Toxicology. CRC Press. ISBN 0849388090.
  23. ^ Jähnichen, S.; Horowski, R.; Pertz, H. Template:PDFlink Presentation. Retrieved on 2007-03-30.
  24. ^ ADRAC (2004). "Cardiac valvulopathy with pergolide". Aust Adv Drug React Bull. 23 (4). {{cite journal}}: Unknown parameter |month= ignored (help) Free full text from the Australian Therapeutic Goods Administration
  25. ^ Schade, Rene; Andersohn, Frank; Suissa, Samy; Haverkamp, Wilhelm; Garbe, Edeltraut (2007-01-04), "Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation", New England Journal of Medicine, 356 (1): 29–38, PMID 17202453 {{citation}}: Check date values in: |date= (help)CS1 maint: date and year (link)
  26. ^ Zanettini, Renzo; Antonini, Angelo; Gatto, Gemma; Gentile, Rosa; Tesei, Silvana; Pezzoli, Gianna (2007-01-04), "Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease", New England Journal of Medicine, 356 (1): 39–46, PMID 17202454 {{citation}}: Check date values in: |date= (help)CS1 maint: date and year (link)
  27. ^ "Food and Drug Administration Public Health Advisory". 2007-03-29. Retrieved 2007-04-27. {{cite web}}: Check date values in: |date= (help)
  28. ^ "MedWatch - 2007 Safety Information Alerts. Permax (pergolide) and generic equivalents". U.S. Food and Drug Administration. March 29, 2007. Retrieved 2007-03-30.
  29. ^ Johnson, D. J.; Sanderson, H.; Brain, R. A.; Wilson, C. J.; Solomon, K. R. (2007). "Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae". Ecotoxicol. Environ. Saf. 67 (1): 128–39. doi:10.1016/j.ecoenv.2006.03.016. PMID 16753215.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  30. ^ McGowan, K.; Kane, A.; Asarkof, N.; et al. (1983). "Entamoeba histolytica causes intestinal secretion: role of serotonin". Science. 221 (4612): 762–4. doi:10.1126/science.6308760. PMID 6308760. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  31. ^ McGowan, K.; Guerina, V.; Wicks, J.; Donowitz, M. (1985). "Secretory hormones of Entamoeba histolytica". Ciba Found. Symp. 112: 139–54. PMID 2861068.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  32. ^ Banu, Naheed; et al. (2005). "Neurohumoral alterations and their role in amoebiasis" (PDF). Indian J. Clin Biochem. 20 (2): 142–5. doi:10.1007/BF02867414. {{cite journal}}: Explicit use of et al. in: |author= (help)
  33. ^ Acharya, D. P.; Sen, M. R.; Sen, P. C. (1989). "Effect of exogenous 5-hydroxytryptamine on pathogenicity of Entamoeba histolytica in experimental animals". Indian J. Exp. Biol. 27 (8): 718–20. PMID 2561282.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  34. ^ Feldman, J. M.; Lee, E. M. (1985). "Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid". Am. J. Clin. Nutr. 42 (4): 639–43. PMID 2413754. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  35. ^ Rapport, Maurice M.; Green, Arda A.; Page, Irvine H. (1948). "Serum vasoconstrictor (serotonin). IV. Isolation and characterization". J. Biol. Chem. 176 (3): 1243–51. PMID 18100415. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  36. ^ a b Young, S. N. (2007). "How to increase serotonin in the human brain without drugs" (PDF). J. Psychiatry Neurosci. 32 (6): 394–9. PMC 2077351. PMID 18043762. {{cite journal}}: Unknown parameter |month= ignored (help)
  37. ^ http://www.selfgrowth.com/articles/Nutritional_Pharmacology_of_Sleep_Depression.html
  38. ^ http://serendip.brynmawr.edu/bb/neuro/neuro99/web1/Byrd.html
  39. ^ http://books.google.com/books?id=2PxhgaCThccC&pg=PA49&lpg=PA49&dq=insulin+resistance+and+serotonin&source=web&ots=udW-o42zjY&sig=rtcdA8TTAkuxSxwvrR4TxYcnF30&hl=en&sa=X&oi=book_result&resnum=3&ct=result#PPA64,M1
  40. ^ http://apollohealth.com/light_therapy_education.html
Retrieved from "https://en.wikipedia.org/w/index.php?title=Serotonin&oldid=255936482"